A Phase I/II Trial of Bortezomib, Low Dose Intravenous Melphalan and Dexamethasone for Patients with Relapsed Multiple Myeloma.

Publisher Website

Abstract

This research paper explore the methodology and findings associated with Blood. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now